Literature DB >> 22651911

Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease.

Ju-Yi Chen1, Chang-Hua Chou, Wei-Chuan Tsai, Ming-Cheng Wang, Chin-Shan Ho, Yi-Heng Li, Yau-Sheng Tsai, Liang-Miin Tsai.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is associated with increasing arterial stiffness. We studied the effects of inflammation on different measurements of arterial stiffness in NAFLD. We recruited 80 patients with NAFLD and 40 control subjects. Both compliance index (CI) and stiffness index (SI) were measured. Patients with NAFLD had significantly lower CI (3.8 ± 2.1 vs 4.9 ± 2.9 units; P < .05) and higher SI (8.5 ± 2.4 vs 7.1 ± 1.5 m/s; P < .05) than the controls. Patients with NAFLD were further divided into 2 groups according to the median level of high-sensitivity C-reactive protein (hs-CRP). The CI was significantly lower in patients with NAFLD with high hs-CRP than in those with low hs-CRP (3.2 ± 1.7 vs 4.4 ± 2.5 units; P < .05); however, SI was not statistically different. We further found that waist circumference (odds ratio, 1.06; 95% confidence interval, 1.01-1.13; P < .05) was the only independent factor that predicted low CI (<median value) in patients with NAFLD. Central obesity was an important determinant both for increased arterial stiffness and hs-CRP in Patients with NAFLD.
Copyright © 2012 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22651911     DOI: 10.1016/j.jash.2012.04.003

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  8 in total

1.  Effects of habitual aerobic exercise on the relationship between intramyocellular or extramyocellular lipid content and arterial stiffness.

Authors:  N Hasegawa; S Fujie; T Kurihara; T Homma; K Sanada; K Sato; T Hamaoka; M Iemitsu
Journal:  J Hum Hypertens       Date:  2016-05-12       Impact factor: 3.012

Review 2.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population.

Authors:  Xin-yan Yu; Yi Zhao; Xiao-xiao Song; Zhen-ya Song
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

4.  Change in levels of C-reactive protein (CRP) and serum cortisol in morbidly obese patients after laparoscopic sleeve gastrectomy.

Authors:  Jaime Ruiz-Tovar; Inmaculada Oller; Isabel Galindo; Carolina Llavero; Antonio Arroyo; Alicia Calero; María Diez; Lorea Zubiaga; Rafael Calpena
Journal:  Obes Surg       Date:  2013-06       Impact factor: 4.129

5.  Compliance Index, a Marker of Peripheral Arterial Stiffness, may Predict Renal Function Decline in Patients with Chronic Kidney Disease.

Authors:  Te-Hui Kuo; Deng-Chi Yang; Wei-Hung Lin; Chin-Chung Tseng; Ju-Yi Chen; Chin-Shan Ho; Meng-Fu Cheng; Wei-Chuan Tsai; Ming-Cheng Wang
Journal:  Int J Med Sci       Date:  2015-06-12       Impact factor: 3.738

6.  The impact of bariatric surgery on nutritional status of patients.

Authors:  Marta Jastrzębska-Mierzyńska; Lucyna Ostrowska; Hady Razak Hady; Jacek Dadan; Emilia Konarzewska-Duchnowska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-01-14       Impact factor: 1.195

7.  The effect of acute maximal exercise on postexercise hemodynamics and central arterial stiffness in obese and normal-weight individuals.

Authors:  Kanokwan Bunsawat; Sushant M Ranadive; Abbi D Lane-Cordova; Huimin Yan; Rebecca M Kappus; Bo Fernhall; Tracy Baynard
Journal:  Physiol Rep       Date:  2017-04

8.  PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity.

Authors:  Ju-Yi Chen; Yi-Pin Wu; Chih-Yi Li; Huei-Fen Jheng; Ling-Zhen Kao; Ching-Chun Yang; Sy-Ying Leu; I-Chia Lien; Wen-Tsan Weng; Haw-Chih Tai; Yu-Wei Chiou; Ming-Jer Tang; Pei-Jane Tsai; Yau-Sheng Tsai
Journal:  J Biomed Sci       Date:  2021-03-29       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.